Silver nanoparticles are particles in the size ranging between 1 and 100 nm. The two major methods used for synthesis of silver nanoparticle are the physical and chemical methods with the disadvantage that they are expensive and can also have toxicity. Biological method is being used as an expedient alternative, as this approach is environment-friendly and less toxic and it includes plant extracts, microorganism, fungi, etc. The major applications of silver nanoparticles in the medical field include diagnostic applications and therapeutic applications, apart from its antimicrobial activity. Due to their nanotoxicity, AgNPs have a several drawbacks too. This review presents a complete view of the mechanism of action, synthesis, the pharmacokinetics of silver nanoparticles, different formulations of AgNPs used in biomedical applications, infertility management, antibacterial effects, skin damage, burns, cancer treatment, etc. and various applications of silver nanoparticles together with the possible toxicological challenge.
Keywords: Silver nanoparticles; applications; formulations; mechanism; synthesis; toxicity.
Khan AU, Malik N, Khan M, Cho MH, Khan MM. Khan AU, et al. Bioprocess Biosyst Eng. 2018 Jan;41(1):1-20. doi: 10.1007/s00449-017-1846-3. Epub 2017 Sep 30. Bioprocess Biosyst Eng. 2018. PMID: 28965140 Review.
Noga M, Milan J, Frydrych A, Jurowski K. Noga M, et al. Int J Mol Sci. 2023 Mar 7;24(6):5133. doi: 10.3390/ijms24065133. Int J Mol Sci. 2023. PMID: 36982206 Free PMC article. Review.
Barkat MA, Harshita, Beg S, Naim MJ, Pottoo FH, Singh SP, Ahmad FJ. Barkat MA, et al. Recent Pat Antiinfect Drug Discov. 2018;13(1):53-69. doi: 10.2174/1574891X12666171006102833. Recent Pat Antiinfect Drug Discov. 2018. PMID: 28990540 Review.
Kummara S, Patil MB, Uriah T. Kummara S, et al. Biomed Pharmacother. 2016 Dec;84:10-21. doi: 10.1016/j.biopha.2016.09.003. Epub 2016 Sep 14. Biomed Pharmacother. 2016. PMID: 27621034
Paiva-Santos AC, Herdade AM, Guerra C, Peixoto D, Pereira-Silva M, Zeinali M, Mascarenhas-Melo F, Paranhos A, Veiga F. Paiva-Santos AC, et al. Int J Pharm. 2021 Mar 15;597:120311. doi: 10.1016/j.ijpharm.2021.120311. Epub 2021 Feb 1. Int J Pharm. 2021. PMID: 33539998 Review.
Dantas LR, Ortis GB, Suss PH, Tuon FF. Dantas LR, et al. Biology (Basel). 2024 Aug 10;13(8):605. doi: 10.3390/biology13080605. Biology (Basel). 2024. PMID: 39194543 Free PMC article. Review.
Ali AH, Hachem M, Ahmmed MK. Ali AH, et al. Heliyon. 2024 May 9;10(9):e30946. doi: 10.1016/j.heliyon.2024.e30946. eCollection 2024 May 15. Heliyon. 2024. PMID: 38774069 Free PMC article. Review.
Taati H, Sangani H, Davoudi A, Safabakhsh Kouchesfahani S, Hedayati M, Tarashandeh Hemmati S, Ghasemipour T, Aghajani S, Farah Andooz M, Amanollahi M, Kalavari F, Salehzadeh A. Taati H, et al. Sci Rep. 2024 Feb 15;14(1):3809. doi: 10.1038/s41598-024-54344-x. Sci Rep. 2024. PMID: 38360831 Free PMC article.
Al-Badwy AH, Khalil AM, Bashal AH, Kebeish R. Al-Badwy AH, et al. Microb Cell Fact. 2023 Dec 5;22(1):247. doi: 10.1186/s12934-023-02257-1. Microb Cell Fact. 2023. PMID: 38053190 Free PMC article.
Liu H, Huang Z, Chen H, Zhang Y, Yu P, Hu P, Zhang X, Cao J, Zhou T. Liu H, et al. J Nanobiotechnology. 2023 Nov 6;21(1):409. doi: 10.1186/s12951-023-02149-x. J Nanobiotechnology. 2023. PMID: 37932843 Free PMC article.